Population longitudinal analysis of Gait Profile Score and North Star Ambulatory Assessment in children with Duchenne muscular dystrophy
CPT: Pharmacometrics & Systems Pharmacology · 2024-05 · 13 (5) · 891-903
DOI: 10.1002/psp4.13126 ↗Kurz gefasst
Fachartikel in der Zeitschrift CPT: Pharmacometrics & Systems Pharmacology, online erschienen am 27.03.2024. Verfasst von Jiexin Deng und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Nursing and Health, Henan University, Kaifeng, China. Hauptthemen laut MEDLINE: Muscular Dystrophy, Duchenne, Disease Progression, Gait. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Duchenne muscular dystrophy (DMD) is a rare X‐linked recessive disorder characterized by loss‐of‐function mutations in the gene encoding dystrophin. These mutations lead to progressive functional deterioration including muscle weakness, respiratory insufficiency, and musculoskeletal deformities. Three‐dimensional gait analysis (3DGA) has been used as a tool to analyze gait pathology through the quantification of altered joint kinematics, kinetics, and muscle activity patterns. Among 3DGA indices, the Gait Profile Score (GPS), has been used as a sensitive overall measure to detect clinically relevant changes in gait patterns in children with DMD. To enhance our understanding of the clinical translation of 3DGA, we report here the development of a population nonlinear mixed‐effect model that jointly describes the disease progression of the 3DGA index, GPS, and the functional endpoint, North Star Ambulatory Assessment (NSAA). The final model consists of a quadratic structure for GPS progression and a linear structure for GPS‐NSAA correlation. Our model was able to capture the improvement in function in GPS and NSAA in younger subjects, as well as the decline of function in older subjects. Furthermore, the model predicted NSAA (CFB) at 1 year reasonably well for DMD subjects ≤7 years old at baseline. The model tended to slightly underpredict the decline in NSAA after 1 year for those >7 years old at baseline, but the prediction summary statistics were well maintained within the standard deviation of observed data. Quantitative models such as this may help answer clinically relevant questions to facilitate the development of novel therapies in DMD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- School of Nursing and Health, Henan University, Kaifeng, China.
- Department of Orthopedics, First Affiliated Hospital of Henan University, Kaifeng, China.
ORCID-Profile: Jiexin Deng, Fangli Liu
Zitieren
APA
Deng, J., Liu, F., Feng, Z., & Liu, Z. (2024). Population longitudinal analysis of Gait Profile Score and North Star Ambulatory Assessment in children with Duchenne muscular dystrophy. CPT: Pharmacometrics & Systems Pharmacology, 13(5), 891-903. https://doi.org/10.1002/psp4.13126
Vancouver
Deng J, Liu F, Feng Z, Liu Z. Population longitudinal analysis of Gait Profile Score and North Star Ambulatory Assessment in children with Duchenne muscular dystrophy. CPT: Pharmacometrics & Systems Pharmacology. 2024;13(5):891-903. doi:10.1002/psp4.13126
BibTeX
@article{Deng2024,
author = {Deng, Jiexin and Liu, Fangli and Feng, Zhifen and Liu, Zhigang},
title = {Population longitudinal analysis of Gait Profile Score and North Star Ambulatory Assessment in children with Duchenne muscular dystrophy},
journal = {CPT: Pharmacometrics & Systems Pharmacology},
year = {2024},
volume = {13},
number = {5},
pages = {891--903},
doi = {10.1002/psp4.13126}
}
EUVIMED